Splenic thrombosis complicating pregnancy in patients with poor obstetrical outcome a report of four cases

1993 ◽  
Vol 66 (6) ◽  
pp. 319-321 ◽  
Author(s):  
A. Pajor ◽  
D. Lehoczky
Keyword(s):  
Obstetrical Outcome ◽  
Splenic Thrombosis

Isolated Gastric Varices and Use of Balloon-occlusive Retrograde Transvenous Obliteration: A Case Report and Literature Review*

2016 ◽  
Vol 25 (1) ◽  
pp. 115-117
Author(s):  
Thomas R. McCarty ◽  
Mena Bakhit ◽  
Tarun Rustagi
Keyword(s):  
Treatment Approach ◽  
Alcoholic Cirrhosis ◽  
Gastric Varices ◽  
Portosystemic Shunt ◽  
Asian Countries ◽  
End Stage Liver Disease ◽  
Intrahepatic Portosystemic Shunt ◽  
Isolated Gastric Varices ◽  
Splenic Thrombosis ◽  
End Stage

Isolated gastric varices are far less prevalent in Western countries where the rate of splenic thrombosis is much lower. However, in Asian countries the entity is more common and therefore a more robust treatment approach has been developed. Balloon-occlusive retrograde transvenous obliteration (BRTO) was first described in 1984 and then revived in 1996. The procedure, while uncommon in the U.S. and not recognized by the AASLD practice guidelines, allows for direct exclusion from the portosystemic system. Here we describe the case of a patient with alcoholic cirrhosis decompensated by bleeding gastric varices treated with BRTO. Abbrevations: BRTO: balloon-occlusive retrograde transverse obliteration; EGD: esophagogastro-duodenoscopy; HE: hepatic encephalopathy; MELD: Model for End Stage Liver Disease; TIPS: transjugular intrahepatic portosystemic shunt.

scholarly journals 388 Evaluation of risk of preterm birth and obstetrical outcome stratified by fetal intervention

2021 ◽  
Vol 224 (2) ◽  
pp. S252
Author(s):  
Kavita Narang ◽  
Eniola Ibirogba ◽  
Haleh Sangi-Haghpeykar ◽  
Rodrigo Ruano
Keyword(s):  
Preterm Birth ◽  
Fetal Intervention ◽  
Obstetrical Outcome

scholarly journals Misoprostol vs dinoprostone vaginal insert in labour induction: comparison of obstetrical outcome

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jakub Mlodawski ◽  
Marta Mlodawska ◽  
Justyna Armanska ◽  
Grzegorz Swiercz ◽  
Stanisław Gluszek
Keyword(s):  
Caesarean Section ◽  
Retrospective Cohort ◽  
Clinical Status ◽  
Labour Induction ◽  
Fetal Membranes ◽  
Vacuum Extraction ◽  
Biochemical Status ◽  
Constant Rate ◽  
Unfavourable Cervix ◽  
Obstetrical Outcome

AbstractInduction of labour (IOL) is increasingly used in obstetric practice. For patients with unfavourable cervix, we are constantly looking for an optimal, in terms of effectiveness and safety, ripening of cervix protocol. It was retrospective cohort study. We analyzed obstetrical results in 481 patients undergoing IOL in one center using two different vaginal inserts that release prostaglandins at a constant rate for 24 h—misoprostol vaginal insert (MVI) with 200 µg of misoprostol (n = 367) and dinoprostone vaginal insert (DVI) with 10 mg of dinoprostone (n = 114). Full-term, single pregnancy patients with intact fetal membranes and the cervix evaluated in Bishop score ≤ 6 were included in the analysis. In the group of MVI patients, the labour ended with caesarean section more often (OR 2.71 95% CI 1.63–4.47) and more frequent unreassuring cardiotocographic trace indicating the surgical delivery occurred (OR 2.38 95% CI 1.10–5.17). We did not notice any differences in the percentage of vacuum extraction and patients in whom the use of oxytocin was necessary during labour induction. The clinical status of newborns after birth and the pH of cord blood did not differ between groups.The use of MVI 200 μg in patients with an unriped cervix is associated with a greater chance of completing delivery by caesarean section and increased chance of abnormal intrapartum CTG trace compared to the use of DVI 10 mg. These differences do not affect the clinical and biochemical status of the newborn.

Obstetrical Outcome and Complications of Pregnancy

2013 ◽  
pp. 128-135
Author(s):  
Borthen Ingrid ◽  
Gilhus Nils Erik
Keyword(s):  
Obstetrical Outcome

A Decision Aid May Offer Liability Protection for a Bad Obstetrical Outcome: Results of Mock Trials

2018 ◽  
Vol 46 (4) ◽  
pp. 967-974 ◽  
Author(s):  
Suzanne Brodney ◽  
Pamela H. Wescott ◽  
Benjamin W. Moulton ◽  
Katherine Hartmann ◽  
Yuchiao Chang ◽  
...  
Keyword(s):  
Decision Aid ◽  
Medical Liability ◽  
Patient Decision Aid ◽  
Malpractice Claim ◽  
Trial Of Labor ◽  
Patient Decision ◽  
Obstetrical Outcome ◽  
Mock Trials

The objective of this study is to evaluate if use of a patient decision aid (PDA), when choosing between a repeat cesarean or a trial of labor after a cesarean (TOLAC), reduces medical liability exposure. The authors conclude that use of a PDA conferred liability protection when potential jurors were presented with a hypothetical malpractice claim against an obstetrician following a TOLAC.

scholarly journals The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies

2016 ◽  
Vol 115 (02) ◽  
pp. 285-290 ◽  
Author(s):  
Savino Sciascia ◽  
D. Ware Branch ◽  
Roger A. Levy ◽  
Saskia Middeldorp ◽  
Sue Pavord ◽  
...  
Keyword(s):  
Pregnancy Outcome ◽  
Clinical Judgment ◽  
Fetal Outcome ◽  
Current Treatment ◽  
Low Dose Aspirin ◽  
Improve Pregnancy Outcome ◽  
Obstetric Antiphospholipid Syndrome ◽  
Obstetric Aps ◽  
Obstetrical Outcome

SummaryThe use of low-dose aspirin and heparinoids has improved the pregnancy outcome in obstetric antiphospholipid syndrome (APS). However, current treatment fails in 20–30 % of APS pregnancies, raising the need to explore other treatments to improve obstetrical outcome. Hydroxychloroquine (HCQ) is widely used in patients with autoimmune diseases, mainly systemic lupus erythematous (SLE), due to its anti-inflammatory, anti-aggregant and immune-regulatory properties. Evidence from in vitro and animal models suggests a potential protective effect of HCQ in obstetric APS. Pending the availability of prospective trials, we aimed to systematically review the available evidence and to assess the clinical judgment of a panel of experts regarding the use of HCQ in improving pregnancy outcome in women with anti-phospholipid antibodies (aPL). Clinical data on the ability of HCQ to improve pregnancy outcome in women with aPL are very limited in the available literature. Only one cohort study evaluating maternal and fetal outcome of pregnancy in patients with SLE who were exposed to HCQ was identified. Four of 14 (29 %) treated with HCQ patients had pregnancy failure, compared with six of 24 (25 %) of patients not treated with HCQ. However, the effect of HCQ was not adjusted for the use of other medications such as aspirin, heparins or steroids. Selected experts were contacted by e-mail and asked to review the summary of the evidence provided by the working group and to briefly answer each of the proposed questions. Overall, the panel of experts agreed that adding HCQ could be considered in selected cases or after failure of standard treatment with aspirin and a heparin agent. Specifically, the majority of experts considered adding HCQ in specific scenarios, such as women with previous thrombosis (either arterial and/or venous), and/or with previous ischaemic placenta-mediated complications. Prospective studies are necessary before the use of HCQ during pregnancy in women with aPL should be routinely recommended for clinical practice.

Effect of Prenatal Care on Obstetrical Outcome

1996 ◽  
Vol 5 (3) ◽  
pp. 142-150
Author(s):  
Saeid B. Amini ◽  
Patrick AA. Catalano ◽  
Leon I. Mann
Keyword(s):  
Prenatal Care ◽  
Obstetrical Outcome

Effect of prenatal care on obstetrical outcome

1996 ◽  
Vol 5 (3) ◽  
pp. 142-150 ◽  
Author(s):  
Sa�id B. Amini ◽  
Patrick M. Catalano ◽  
Leon I. Mann
Keyword(s):  
Prenatal Care ◽  
Obstetrical Outcome
Sign in / Sign up

Export Citation Format

Share Document